European Molecular Biology Laboratory, 71 avenue des Martyrs, 38042 Grenoble, France.
Munich Cluster for Systems Neurology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.
Sci Adv. 2024 Aug 9;10(32):eadp3000. doi: 10.1126/sciadv.adp3000.
Over 600 E3 ligases in humans execute ubiquitination of specific target proteins in a spatiotemporal manner to elicit desired signaling effects. Here, we developed a ubiquitin-specific proximity-based labeling method to selectively biotinylate substrates of a given ubiquitin ligase. By fusing the biotin ligase BirA and an Avi-tag variant to the candidate E3 ligase and ubiquitin, respectively, we were able to specifically enrich bona fide substrates of a ligase using a one-step streptavidin pulldown under denaturing conditions. We applied our method, which we named Ub-POD, to the really interesting new gene (RING) E3 ligase RAD18 and identified proliferating cell nuclear antigen and several other critical players in the DNA damage repair pathway. Furthermore, we successfully applied Ub-POD to the RING ubiquitin ligase tumor necrosis factor receptor-associated factor 6 and a U-box-type E3 ubiquitin ligase carboxyl terminus of Hsc70-interacting protein. We anticipate that our method could be widely adapted to all classes of ubiquitin ligases to identify substrates.
在人类中,超过 600 种 E3 连接酶以时空方式执行特定靶蛋白的泛素化,以引发所需的信号效应。在这里,我们开发了一种基于泛素特异性接近的标记方法,以选择性地生物素标记给定泛素连接酶的底物。通过将生物素连接酶 BirA 和 Avi 标签变体分别融合到候选 E3 连接酶和泛素上,我们能够在变性条件下通过一步链霉亲和素下拉特异性富集连接酶的真正底物。我们将我们的方法(命名为 Ub-POD)应用于真核基因(RING)E3 连接酶 RAD18,并鉴定出增殖细胞核抗原和 DNA 损伤修复途径中的其他几个关键参与者。此外,我们成功地将 Ub-POD 应用于 RING 泛素连接酶肿瘤坏死因子受体相关因子 6 和 U 盒型 E3 泛素连接酶热休克蛋白 70 相互作用蛋白羧基末端。我们预计,我们的方法可以广泛适用于所有类别的泛素连接酶,以鉴定底物。